
Equillium, Inc.
EQNasdaqCIK 1746466HealthcareFiscal year ends Dec 31
Reports and events: 158 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2206:08 ET | 8-K | 8.01 Other events | 0001193125-24-041994 |
| 2023-12-2108:05 ET | 8-K | 8.01 Other events | 0001193125-23-300417 |
| 2023-11-0816:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061108 |
| 2023-11-0816:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-061084 |
| 2023-10-1608:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-256538 |
| 2023-10-0517:28 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-23-251681 |
| 2023-08-0916:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040583 |
| 2023-08-0916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040564 |
| 2023-05-2516:00 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-23-154186 |
| 2023-05-2316:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-151783 |
| 2023-05-1116:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021236 |
| 2023-05-1116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021215 |
| 2023-04-1116:01 ET | DEF 14A | Proxy statementPeriod 2023-05-22 | 0001193125-23-097790 |
| 2023-04-0616:02 ET | 8-K | 3.01 Delisting notice | 0001193125-23-093949 |
| 2023-03-2316:13 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-009492 |
| 2023-03-2316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-077853 |
| 2022-12-2316:11 ET | 8-K | 1.02 Termination of a material agreement; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-311788 |
| 2022-12-1521:49 ET | 8-K | 8.01 Other events | 0001193125-22-305076 |
| 2022-12-0607:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-298869 |
| 2022-11-1417:17 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-025052 |
| 2022-11-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-024988 |
| 2022-09-2709:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-251807 |
| 2022-09-2617:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-251386 |
| 2022-09-0616:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-238883 |
| 2022-08-1516:50 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-017399 |
| 2022-08-1516:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-017382 |
| 2022-05-2516:57 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-159792 |
| 2022-05-1216:12 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009669 |
| 2022-05-1216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-009653 |
| 2022-05-0908:06 ET | 8-K | 8.01 Other events | 0001193125-22-144343 |
| 2022-05-0213:19 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000950170-22-006823 |
| 2022-04-2508:05 ET | 8-K | 8.01 Other events | 0001193125-22-116380 |
| 2022-04-1316:06 ET | DEF 14A | Proxy statementPeriod 2022-05-24 | 0001193125-22-104267 |
| 2022-03-2316:09 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-004407 |
| 2022-03-2316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-004404 |
| 2022-03-0414:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-002895 |
| 2022-03-0209:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-002622 |
| 2022-02-1607:01 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-043939 |
| 2021-11-1016:11 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004079 |
| 2021-11-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-004068 |
| 2021-08-1016:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-001180 |
| 2021-08-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-001177 |
| 2021-07-1216:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-21-000445 |
| 2021-06-1415:57 ET | 8-K | 8.01 Other events | 0000950170-21-000348 |
| 2021-06-1107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-21-000344 |
| 2021-06-1011:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-21-000338 |
| 2021-06-0715:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-21-000318 |
| 2021-05-2809:05 ET | 8-K | 5.07 Shareholder vote results | 0000950123-21-007391 |
| 2021-05-1316:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000950170-21-000224 |
| 2021-05-1316:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-000223 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:43 ET. Listed shows no prices and gives no investment advice.